Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Xencor Inc

NASDAQ: XNCR · Life Sciences · 4 alerts · CIK 1326732

Share price
$35.40Close, Nov 16
Market cap
$2.66B
Shares outstanding
75.04MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Xencor Inc filings on SEC EDGAR ↗

7:51 AM ET 8-K
Clinical Trial Data

Xencor Clinical Trial Data

Xencor announced updated Phase 1 clinical trial results for XmAb819, an ENPP3 x CD3 bispecific T-cell engager, in patients with advanced clear cell renal cell carcinoma (ccRCC). The company also provided a cash runway update, expecting current resources to fund operations into 2029, and plans to start a potential registration-enabling study for XmAb819 in 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.